1.Lemos B et al. Pathologic Nodal Evaluation Improved Prognostic Accuracy in Merkel Cell Carcinoma: Analysis of 5,823 Cases as the Basis of the First Consensus Staging System for this Cancer. Journal of the American Academy of Dermatology 2010;63:751¡V761.
2.NCCN Merkel Cell Carcinoma Guidelines Version I. 2017. Available from: www.nccn.org/professionals/physician_gls/PDF/mcc.pdf. Accessed August 2017.
3.Christopher K. Bichakjian, MD; Thomas Olencki, DO; Sumaira Z. Aasi, MD; Murad Alam, MD, MBA, MSCI; James S. Andersen, MD; Rachel Blitzblau, MD, PhD; Glen M. Bowen, MD; Carlo M. Contreras, MD; Gregory A. Daniels, MD, PhD; Roy Decker, MD, PhD;Jeffrey M. Farma, MD; Kris Fisher, MD; Brian Gastman, MD; Karthik Ghosh, MD; Roy C. Grekin, MD;Kenneth Grossman, MD, PhD; Alan L. Ho, MD, PhD; Karl D. Lewis, MD; Manisha Loss, MD;Daniel D. Lydiatt, DDS, MD; Jane Messina, MD; Kishwer S. Nehal, MD; Paul Nghiem, MD, PhD;Igor Puzanov, MD, MSCI; Chrysalyne D. Schmults, MD, MS;Ashok R. Shaha, MD; Valencia Thomas, MD; Yaohui G. Xu, MD, PhD; John A. Zic, MD;Karin G. Hoffmann, RN, CCM; and Anita M. Engh, PhDMerkel Cell Carcinoma, Version 1.2018
4.Author Patricia Tai, MB, BS, DABR, FRCR, FRCPC. Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma
¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡Aì¤åµoªí
©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ´¿¥¿»¨³ø¾É¡j2019/05/06